274 related articles for article (PubMed ID: 35080746)
1. Dual-specificity Tyrosine Phosphorylation-regulated Kinase Inhibitor ID-8 Promotes Human Somatic Cell Reprogramming by Activating PDK4 Expression.
Xu J; Fang S; Wang N; Li B; Huang Y; Fan Q; Shi J; Liu H; Shao Z
Stem Cell Rev Rep; 2022 Aug; 18(6):2074-2087. PubMed ID: 35080746
[TBL] [Abstract][Full Text] [Related]
2. Wnt signaling orchestration with a small molecule DYRK inhibitor provides long-term xeno-free human pluripotent cell expansion.
Hasegawa K; Yasuda SY; Teo JL; Nguyen C; McMillan M; Hsieh CL; Suemori H; Nakatsuji N; Yamamoto M; Miyabayashi T; Lutzko C; Pera MF; Kahn M
Stem Cells Transl Med; 2012 Jan; 1(1):18-28. PubMed ID: 23197636
[TBL] [Abstract][Full Text] [Related]
3. HIF1α modulates cell fate reprogramming through early glycolytic shift and upregulation of PDK1-3 and PKM2.
Prigione A; Rohwer N; Hoffmann S; Mlody B; Drews K; Bukowiecki R; Blümlein K; Wanker EE; Ralser M; Cramer T; Adjaye J
Stem Cells; 2014 Feb; 32(2):364-76. PubMed ID: 24123565
[TBL] [Abstract][Full Text] [Related]
4. Kinome-wide functional analysis highlights the role of cytoskeletal remodeling in somatic cell reprogramming.
Sakurai K; Talukdar I; Patil VS; Dang J; Li Z; Chang KY; Lu CC; Delorme-Walker V; Dermardirossian C; Anderson K; Hanein D; Yang CS; Wu D; Liu Y; Rana TM
Cell Stem Cell; 2014 Apr; 14(4):523-34. PubMed ID: 24702998
[TBL] [Abstract][Full Text] [Related]
5. Positioning canine induced pluripotent stem cells (iPSCs) in the reprogramming landscape of naïve or primed state in comparison to mouse and human iPSCs.
Menon DV; Bhaskar S; Sheshadri P; Joshi CG; Patel D; Kumar A
Life Sci; 2021 Jan; 264():118701. PubMed ID: 33130086
[TBL] [Abstract][Full Text] [Related]
6. Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells.
Ruiz S; Diep D; Gore A; Panopoulos AD; Montserrat N; Plongthongkum N; Kumar S; Fung HL; Giorgetti A; Bilic J; Batchelder EM; Zaehres H; Kan NG; Schöler HR; Mercola M; Zhang K; Izpisua Belmonte JC
Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16196-201. PubMed ID: 22991473
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation dynamics in human induced pluripotent stem cells.
Nishino K; Umezawa A
Hum Cell; 2016 Jul; 29(3):97-100. PubMed ID: 27083573
[TBL] [Abstract][Full Text] [Related]
8. Mass cytometry-based single-cell analysis of human stem cell reprogramming uncovers differential regulation of specific pluripotency markers.
Im I; Son YS; Jung KB; Kang I; Teh BE; Lee KB; Son MY; Kim J
J Biol Chem; 2019 Dec; 294(49):18547-18556. PubMed ID: 31570522
[TBL] [Abstract][Full Text] [Related]
9. CDK1-PDK1-PI3K/Akt signaling pathway regulates embryonic and induced pluripotency.
Wang XQ; Lo CM; Chen L; Ngan ES; Xu A; Poon RY
Cell Death Differ; 2017 Jan; 24(1):38-48. PubMed ID: 27636107
[TBL] [Abstract][Full Text] [Related]
10. Serum starvation-induced cell cycle synchronization stimulated mouse rDNA transcription reactivation during somatic cell reprogramming into iPSCs.
Zhao Q; Wu Y; Shan Z; Bai G; Wang Z; Hu J; Liu L; Li T; Shen J; Lei L
Stem Cell Res Ther; 2016 Aug; 7(1):112. PubMed ID: 27515169
[TBL] [Abstract][Full Text] [Related]
11. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
12. CXCR2 Ligands and mTOR Activation Enhance Reprogramming of Human Somatic Cells to Pluripotent Stem Cells.
Lee SJ; Kang KW; Kim JH; Lee BH; Jung JH; Park Y; Hong SC; Kim BS
Stem Cells Dev; 2020 Feb; 29(3):119-132. PubMed ID: 31808362
[TBL] [Abstract][Full Text] [Related]
13. mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.
Grace HE; Galdun P; Lesnefsky EJ; West FD; Iyer S
Stem Cells Dev; 2019 Jul; 28(13):846-859. PubMed ID: 31017045
[TBL] [Abstract][Full Text] [Related]
14. A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells.
Lu HF; Chai C; Lim TC; Leong MF; Lim JK; Gao S; Lim KL; Wan AC
Biomaterials; 2014 Mar; 35(9):2816-26. PubMed ID: 24411336
[TBL] [Abstract][Full Text] [Related]
15. Pyruvate dehydrogenase kinase 4-mediated metabolic reprogramming is involved in rituximab resistance in diffuse large B-cell lymphoma by affecting the expression of MS4A1/CD20.
Jiang D; Mo Q; Sun X; Wang X; Dong M; Zhang G; Chen F; Zhao Q
Cancer Sci; 2021 Sep; 112(9):3585-3597. PubMed ID: 34252986
[TBL] [Abstract][Full Text] [Related]
16. Metabolic remodeling during somatic cell reprogramming to induced pluripotent stem cells: involvement of hypoxia-inducible factor 1.
Ishida T; Nakao S; Ueyama T; Harada Y; Kawamura T
Inflamm Regen; 2020; 40():8. PubMed ID: 32426078
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
18. The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture.
Tesarova L; Simara P; Stejskal S; Koutna I
PLoS One; 2016; 11(6):e0157974. PubMed ID: 27336948
[TBL] [Abstract][Full Text] [Related]
19. Role of small molecules as drug candidates for reprogramming somatic cells into induced pluripotent stem cells: A comprehensive review.
Rehman A; Fatima I; Noor F; Qasim M; Wang P; Jia J; Alshabrmi FM; Liao M
Comput Biol Med; 2024 Jul; 177():108661. PubMed ID: 38810477
[TBL] [Abstract][Full Text] [Related]
20. PBX homeobox 1 enhances hair follicle mesenchymal stem cell proliferation and reprogramming through activation of the AKT/glycogen synthase kinase signaling pathway and suppression of apoptosis.
Jiang Y; Liu F; Zou F; Zhang Y; Wang B; Zhang Y; Lian A; Han X; Liu Z; Liu X; Jin M; Wang D; Li G; Liu J
Stem Cell Res Ther; 2019 Aug; 10(1):268. PubMed ID: 31443676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
